XOMA Corp (XOMA) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

XOMA XOMA Corp

Watchlist

30.100
+0.080+0.27%

Trading Nov 21 12:26 ET

354.66MMarket Cap-9804P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

XOMA Royalty Corporation (NASDAQ:XOMA) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates
Yahoo FinanceNov 10 09:25 ET
Express News | XOMA Royalty Corp : Leerink Partners Raises Target Price to $55 From $49
ReutersNov 8 06:09 ET
TD Cowen Maintains XOMA Corp(XOMA.US) With Hold Rating
Moomoo NewsNov 7 12:31 ET · Ratings
10-Q: Q3 2024 Earnings Report
SECNov 7 07:38 ET · Announcements
Earnings Flash (XOMA) XOMA CORPORATION Posts Q3 Revenue $7.2M
MT NewswiresNov 7 07:37 ET
XOMA Royalty 3Q Rev $7.2M >XOMA
Dow JonesNov 7 07:34 ET

Comments

$XOMA Corp (XOMA.US)$
XOMA Royalty Acquires 50% of Twist Bioscience's Royalty, Milestone Economics for $15M

0.53906 per share.

$XOMA Corp (XOMA.US)$

0.53906 per share.

0.53906 per share.

$XOMA Corp (XOMA.US)$ $Day One Biopharmaceuticals (DAWN.US)$ XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of Its Priority Review Voucher

2

Biotech Stock News 3/20

$Annovis Bio (ANVS.US)$ 22% Ph2/3 data reporting update
$Taysha Gene Therapies (TSHA.US)$ 21% FY 2023 results
$TFF Pharmaceuticals (TFFP.US)$ 14% Clinical programs update
$Jaguar Health (JAGX.US)$ 14% Crofelemer commercialization
$Acelyrin (SLRN.US)$ 4% Ph1/2 positive data
$Delcath Systems (DCTH.US)$ 3% Closes $7M private placement
$Sellas Life Sciences (SLS.US)$ 0% Closes $20M offering & private placement
$Immunic (IMUX.US)$ 1% Patent notice of allowance
$Nurix Therapeutics (NRIX.US)$ 0...

11

1

Biotech Stock News 01/12 @ Open 🛎️📰
$Dyne Therapeutics (DYN.US)$ 4% Closing of public offering
$Geron (GERN.US)$ 4% Participate @ B. Riley Sec. Conf. '24
$ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (ZEAL.US)$ 2% Capital increase
$XOMA Corp (XOMA.US)$ 1% Arimoclomol NDA filing accepted
$Cellectar BioSciences (CLRB.US)$ 1% Topline results @ conf. call
$CytomX (CTMX.US)$ 0% Present @ B. Riley Sec. Conf. '24

2

Read more

Analysis

Analyst Rating

No Data

Price Target

No Data

US

Overall

No Data